Lex
Map my exposure →

Who lobbies the EU on Pharmaceuticals & Life Sciences?

Pharmaceutical and life-sciences companies face EU rules on medicines authorisation, clinical trials and supply-chain integrity across the single market. These are the EU acts most likely to apply.

Ranked by distinct disclosed European Commission meetings whose topic matches pharmaceuticals & life sciences keywords. 19 organisations appear across 29 such meetings. Every organisation links to the official disclosure.

  1. 1
    AnimalhealthEurope3 mtgs
    e.g. Commission Expert Group on Veterinary Medicinal Products - Article 106(1) of Regulation (EU) 2019/6source ↗
  2. 2
    Access VetMed3 mtgs
    e.g. Commission Expert Group on Veterinary Medicinal Products - Article 106(1) of Regulation (EU) 2019/6source ↗
  3. 3
    European Federation of Pharmaceutical Industries and Associations3 mtgs
    e.g. Competitiveness of the innovative pharmaceutical sector, with specific focus on clinical trials and biotech act.source ↗
  4. 4
    European Organisation for Research and Treatment of Cancer3 mtgs
    e.g. Clinical trialssource ↗
  5. 5
    Federation of Veterinarians of Europe2 mtgs
    e.g. Commission Expert Group on Veterinary Medicinal Products - Article 106(1) of Regulation (EU) 2019/6source ↗
  6. 6
    Bristol-Myers Squibb Company2 mtgs
    e.g. The aim of the meeting was to discuss the possible improvements to the Clinical Trials Regulation, IP frameworks and cell therapy in the Biotech Actsource ↗
  7. 7
    Association of Veterinary Consultants1 mtg
    e.g. Commission Expert Group on Veterinary Medicinal Products - Article 106(1) of Regulation (EU) 2019/6source ↗
  8. 8
    Asociación Agraria Jóvenes Agricultores1 mtg
    e.g. Lumpy Skin disease (LSD) and vaccination - Veterinary medicinal productssource ↗
  9. 9
    CITTADINANZATTIVA APS1 mtg
    e.g. Economic sustainability of Advanced Therapy Medicinal Products (ATMPs) at the European level. (Meeting convened at request of interest representative following a request made to Director-General, followed up at technical level.source ↗
  10. 10
    ALPHAVET Állatgyógyászati Zártkörűen Működő Részvénytársaság1 mtg
    e.g. Animal health and veterinary medicinal productssource ↗
  11. 11
    Miltenyi Biotec1 mtg
    e.g. Biotechnology and clinical trialssource ↗
  12. 12
    Magyarországi Klinikai Vizsgálatszervezők Társasága1 mtg
    e.g. Promoting multi country clinical trialssource ↗
  13. 13
    AstraZeneca PLC1 mtg
    e.g. Exchange of views on multinational clinical trials in the context of the upcoming Biotech Actsource ↗
  14. 14
    SANOFI1 mtg
    e.g. Exchange of views on multinational clinical trials in the context of the upcoming Biotech Actsource ↗
  15. 15
    Breakthrough T1D1 mtg
    e.g. Presentation of Breakthrough T1D, the US based, tax-exempt nonprofit organisation that invests in type 1 diabetes research, and discussion on its role as a research funder supporting multicountry clinical trials within the EUsource ↗
  16. 16
    European Research Infrastructure for Translational Medicine1 mtg
    e.g. Presentation of EATRIS and a discussion on their role as a clinical research infrastructure supporting multi-country clinical trials within the EUsource ↗
  17. 17
    European University Hospital Alliance1 mtg
    e.g. Presentation of the EUHA and a discussion on their role as a network of clinical research hospitals supporting multi-country clinical trials within the EU.source ↗
  18. 18
    Biobanking and Biomolecular resources Research Infrastructure-European Research Infrastructure Consortium1 mtg
    e.g. Presentation of BBMRI-ERIC and discussion on their role as clinical research infrastructure to support multi-country clinical trials in EUsource ↗
  19. 19
    Eli Lilly and Company1 mtg
    e.g. Exchange of views on the Clinical Trials Regulation (CTR), In-Vitro Diagnostic Regulation (IVDR) and their interface. Discussion on the clinical trial environment in Europe and globally.source ↗

Go deeper

The Pharmaceuticals & Life Sciences rulebook →All EU influence footprints →

Frequently asked

Who lobbies the EU on pharmaceuticals & life sciences?

Based on disclosed European Commission meetings, the most active organisations include AnimalhealthEurope, Access VetMed, European Federation of Pharmaceutical Industries and Associations, European Organisation for Research and Treatment of Cancer, Federation of Veterinarians of Europe. 19 organisations appear across 29 disclosed meetings on these topics.

How is "Pharmaceuticals & Life Sciences" lobbying measured here?

By counting distinct, officially disclosed Commission meetings whose topic matches pharmaceuticals & life sciences keywords (medicinal products, clinical trials, veterinary medicinal). These are disclosed meetings, not a measure of influence, and each is linked to its official source.

Primary sources

Rankings count distinct disclosed Commission meetings whose topic matches the sector keywords; they are not a measure of influence. Data © European Union (Decision 2011/833/EU).

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

Where do you sit on pharmaceuticals & life sciences?

Describe your company in a sentence — Lex shows the EU files heading your way and who else is in the room. Free, no signup.

Scan your regulatory exposure →Ask about this sector